Company intelligence / Profile preview

Chongqing Antixin Biotechnology

Chongqing, Chongqing, China

Ownership: Private
Development stage: Other

Overview

Chongqing Antixin Biotechnology is a Chinese biopharmaceutical company specializing in the research and development of mRNA-based vaccines and therapeutics. Established in 2020, the company has developed a comprehensive mRNA technology platform that integrates sequence design, optimization, and lipid nanoparticle (LNP) delivery technologies. Its lead candidate, AX-001, is an mRNA vaccine targeting COVID-19 that has entered Phase 1/2 clinical trials. In addition to infectious disease vaccines for rabies and shingles, Antixin is exploring mRNA applications in oncology and protein replacement therapies. The company operates a modern R&D and manufacturing facility in Chongqing's Liangjiang New Area to support its clinical and commercial goals.

Therapeutic areas: OncologyInfectious Diseases
Modalities: mRNA-based drugsLipid nanoparticle delivery therapyVaccine
Industry: Biotech

Beyond the preview

Go deeper on Chongqing Antixin Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chongqing Antixin Biotechnology.

Explore the full profile